发明名称 METHODS OF USING SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS
摘要 A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at about 12 hours and the use of the composition to treat various neurological diseases, including multiple sclerosis. A method of selecting individuals based on responsiveness to a treatment, including, for example, identifying individuals who responded to treatment with a sustained release fampridine composition.
申请公布号 US2016199358(A1) 申请公布日期 2016.07.14
申请号 US201615079010 申请日期 2016.03.23
申请人 Acorda Therapeutics, Inc. 发明人 BLIGHT Andrew R.;COHEN Ron
分类号 A61K31/435 主分类号 A61K31/435
代理机构 代理人
主权项 1. A method of increasing walking speed comprising administering to a patient with multiple sclerosis an effective amount of a sustained release aminopyridine composition twice daily, wherein said effective amount is less than about 15 milligrams of aminopyridine.
地址 Ardsley NY US